NS
CLPT icon

NBC Securities’s ClearPoint Neuro CLPT Stock Holding History

NBC Securities’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-250
Closed -$2K – 1404
2024
Q3 		$2K Hold
250
– – ﹤0.01% 2004
2024
Q2 		$1K Hold
250
– – ﹤0.01% 2028
2024
Q1 		$1K Hold
250
– – ﹤0.01% 2048
2023
Q4 		$1K Hold
250
– – ﹤0.01% 2052
2023
Q3 		$1K Buy
+250
New +$1.49K ﹤0.01% 2058

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NBC Securities's CLPT Position: Q4 2024 in Review

NBC Securities sold out of ClearPoint Neuro (CLPT) in Q4 2024, closing a stake of 250 shares — an estimated $2K sold.

NBC Securities first reported a position in CLPT in Q3 2023 and held it in 5 quarters. The position peaked at $2K in Q3 2024. 89 funds tracked by Wall St. Rank hold CLPT as of Q4 2024.

  • NBC Securities reported no remaining ClearPoint Neuro position as of Q4 2024 after selling out during the quarter.
  • NBC Securities sold 250 ClearPoint Neuro shares in Q4 2024, an estimated $2K.
  • NBC Securities first reported a position in ClearPoint Neuro in Q3 2023 and held it in 5 quarters.
  • NBC Securities's ClearPoint Neuro position peaked at $2K in Q3 2024.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2024.

Based on NBC Securities's 13F filing for Q4 2024, filed 22 Jan 2025.